Recent studies have demonstrated that the increased expression of xCT in cancer cells is necessary to maintain redox homeostasis and suppress ferroptosis, as well as to reduce their metabolic flexibility since cancer cells become highly dependent on glutamine and glucose as a metabolic consequence of xCT-mediated cystine uptake enhancement [1, 72–75]. This evidence concerns the gene SLC7A11 and cancer.